{"data":[{"accessionNo":"0001193125-26-402801","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Share $0.00001 Par Value","eventDate":"2026-09-23","reportingPerson":"Andrew M. Weiss","reportingCik":"0001357643","personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-09-25","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001193125-26-402801","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Share $0.00001 Par Value","eventDate":"2026-09-23","reportingPerson":"BIP GP LLC","reportingCik":"0001298983","personType":"HC,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-09-25","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001193125-26-402801","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Share $0.00001 Par Value","eventDate":"2026-09-23","reportingPerson":"WAM GP LLC","reportingCik":"0001504664","personType":"HC,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-09-25","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001193125-26-402801","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Share $0.00001 Par Value","eventDate":"2026-09-23","reportingPerson":"Weiss Asset Management LP","reportingCik":"0001357550","personType":"IA,PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-09-25","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001013594-26-000901","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Shares, $0.00001 Par Value (the \"Ordinary Shares\")","eventDate":"2026-06-30","reportingPerson":"Madison Avenue GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":9212252,"percentOfClass":17.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001013594-26-000901","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Shares, $0.00001 Par Value (the \"Ordinary Shares\")","eventDate":"2026-06-30","reportingPerson":"Caraway Jackson Investments LLC","reportingCik":null,"personType":"OO","sharesOwned":9212252,"percentOfClass":17.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001013594-26-000901","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Shares, $0.00001 Par Value (the \"Ordinary Shares\")","eventDate":"2026-06-30","reportingPerson":"Eli Samaha","reportingCik":null,"personType":"IN","sharesOwned":9212252,"percentOfClass":17.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001013594-26-000901","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Shares, $0.00001 Par Value (the \"Ordinary Shares\")","eventDate":"2026-06-30","reportingPerson":"Madison Avenue International LP","reportingCik":null,"personType":"OO","sharesOwned":9212252,"percentOfClass":17.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001013594-26-000901","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Shares, $0.00001 Par Value (the \"Ordinary Shares\")","eventDate":"2026-06-30","reportingPerson":"Madison Avenue Partners, LP","reportingCik":null,"personType":"OO","sharesOwned":9212252,"percentOfClass":17.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001013594-26-000901","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Shares, $0.00001 Par Value (the \"Ordinary Shares\")","eventDate":"2026-06-30","reportingPerson":"EMAI Management, LLC","reportingCik":null,"personType":"OO","sharesOwned":9212252,"percentOfClass":17.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001493152-26-038373","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Share $0.00001 par value","eventDate":"2026-06-30","reportingPerson":"Newtyn Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":3434191,"percentOfClass":6.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001493152-26-038373","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Share $0.00001 par value","eventDate":"2026-06-30","reportingPerson":"Newtyn TE Partners, LP","reportingCik":null,"personType":"PN","sharesOwned":2212712,"percentOfClass":4.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001193125-26-124073","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Share $0.00001 Par Value","eventDate":"2026-03-23","reportingPerson":"WAM GP LLC","reportingCik":"0001504664","personType":"HC,OO","sharesOwned":7457060,"percentOfClass":14.5,"filedAt":"2026-03-25","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001193125-26-124073","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Share $0.00001 Par Value","eventDate":"2026-03-23","reportingPerson":"Weiss Asset Management LP","reportingCik":"0001357550","personType":"IA,PN","sharesOwned":7457060,"percentOfClass":14.5,"filedAt":"2026-03-25","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001193125-26-124073","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Share $0.00001 Par Value","eventDate":"2026-03-23","reportingPerson":"Andrew M. Weiss","reportingCik":"0001357643","personType":"HC,IN","sharesOwned":7457060,"percentOfClass":14.5,"filedAt":"2026-03-25","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001193125-26-124073","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":"G8807B106","securityClass":"Ordinary Share $0.00001 Par Value","eventDate":"2026-03-23","reportingPerson":"BIP GP LLC","reportingCik":"0001298983","personType":"HC,OO","sharesOwned":4628074,"percentOfClass":9,"filedAt":"2026-03-25","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001493152-26-007116","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":null,"securityClass":"Ordinary Share $0.00001 par value","eventDate":"2025-12-31","reportingPerson":"Newtyn Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":4300000,"percentOfClass":8.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"},{"accessionNo":"0001493152-26-007116","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001583107","issuerName":"Theravance Biopharma, Inc.","ticker":"TBPH","cusip":null,"securityClass":"Ordinary Share $0.00001 par value","eventDate":"2025-12-31","reportingPerson":"Newtyn TE Partners, LP","reportingCik":null,"personType":"PN","sharesOwned":2678900,"percentOfClass":5.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tbph"}],"updatedAt":"2026-11-05T12:02:16.171Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/tbph","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}